Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3521831 | 0.85 | CA2 (0.36) | CA2CA1CA9 | |
| SCHEMBL16115817 | 0.81 | CA2 (0.34) | CA2CA1CA9 | |
| SCHEMBL28673552 | 0.81 | CA2 (0.34) | CA2CA1 | |
| SCHEMBL18392909 | 0.81 | — | — | |
| SCHEMBL17629788 | 0.81 | CA2 (0.37) | CA2CA1 | |
| SCHEMBL19713240 | 0.79 | CA2 (0.33) | CA2CA1 | |
| SCHEMBL18762503 | 0.78 | CA2 (0.35) | CA2CA1CA9 | |
| SCHEMBL20267825 | 0.78 | CA2 (0.35) | CA2CA1CA9 | |
| SCHEMBL271903 | 0.78 | CA2 (0.35) | CA2CA1CA9 | |
| SCHEMBL780303 | 0.78 | CA2 (0.35) | CA2CA1CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2614 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250161911-A1 | POLYMERS FOR THE REMOVAL OF PFAS FROM AQUEOUS COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME | GULF COAST ENVIRONMENTAL SYSTEMS LLC (DBA CONIFER SYSTEMS) | 2025-05-22 | — | — | US | claimed |
| WO-2025106778-A1 | POLYMERS FOR THE REMOVAL OF PFAS FROM AQUEOUS COMPOSITIONS, AND METHODS OF MAKING AND USING THE SAME | LUTUM TECHNOLOGY, LLC (US) | 2025-05-22 | — | — | WO | claimed |
| CN-118356775-A | Novel fluorine functionalized alcohol amine-based absorbent for capturing sulfur dioxide in mixed gas, preparation method and application | 大连理工大学 | 2024-07-19 | — | — | CN | claimed |
| CN-101611026-A | Preparation method of (3R,4R) -N- (4-chlorphenyl) -1- (2, 2-difluoroethyl) -N' - [ 2-fluoro-4- (2-oxo-1 (2H) -pyridyl) phenyl ] -3, 4-pyrrolidine dicarboxamide | HOFFMANN LA ROCHE (CH) | 2009-12-23 | — | — | CN | claimed |
| EP-2097401-A1 | PROCESSES FOR THE PREPARATION OF (3R, 4R) -N- (4 -CHLOROPHENYL) -1- (2, 2-DIFLUOROETHYL) -N' - [2-FLUORO-4- (2-OXO-1 (2H) -PYRIDINYL) PHENYL]-3, 4-PYRROLIDINEDICARBOXAMIDE | F. Hoffmann-Roche AG (CH) | 2009-09-09 | — | — | EP | claimed |
| US-20080214826-A1 | PROCESSES FOR THE MANUFACTURE OF A PYRROLIDINE-3,4-DICARBOXAMIDE DERIVATIVE | HOFFMANN-LA ROCHE, INC. | 2008-09-04 | — | — | US | claimed |
| WO-2008077797-A1 | PROCESSES FOR THE PREPARATION OF (3R, 4R) -N- (4 -CHLOROPHENYL) -1- (2, 2-DIFLUOROETHYL) -N' - [2-FLUORO-4- (2-OXO-1 (2H) -PYRIDINYL) PHENYL] -3, 4-PYRROLIDINEDICARBOXAMIDE | F. HOFFMANN-LA ROCHE AG (CH) | 2008-07-03 | — | — | WO | claimed |
| EP-4746963-A1 | MACROCYCLES FOR THE TREATMENT OF AUTOIMMUNE DISEASE | F. Hoffmann-La Roche AG (CH) | 2026-05-27 | — | — | EP | disclosed |
| WO-2026107418-A1 | N-(4-(1H-BENZO[D[IMIDAZOL-6-YL)-PYRIDIN-2-YL)BENZAMIDE DERIVATIVES AS CAMK2 INHIBITORS FOR THE TREATMENT OF HEART FAILURE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2026-05-21 | — | — | WO | disclosed |
| WO-2026103793-A1 | TRICYCLIC COMPOUNDS, PREPARATION METHOD THEREFOR, AND USE THEREOF | 上海翰森生物医药科技有限公司 | 2026-05-21 | — | — | WO | disclosed |
| WO-2026107424-A1 | N-(4-(IMIDAZO[4,5-B]PYRIDIN-5-YL)-2-PYRIDYL)BENZAMIDE DERIVATIVES AS CAMK2 INHIBITORS FOR THE TREATMENT OF HEART FAILURE | BRISTOL-MYERS SQUIBB COMPANY (US) | 2026-05-21 | — | — | WO | disclosed |
| EP-4744661-A2 | NOVEL PYRIMIDIN-2-YL SULFONAMIDE DERIVATIVES | F. Hoffmann-La Roche AG (CH) | 2026-05-20 | — | — | EP | disclosed |
| EP-4743455-A1 | SARM1 INHIBITORS | F. Hoffmann-La Roche AG (CH) | 2026-05-20 | — | — | EP | disclosed |
| US-6218364-B1 | FOR THERAPY OF ASTHMA | MERRELL PHARMACEUTICALS, INC. | 2001-04-17 | — | — | US | disclosed |
| EP-1084137-A1 | PEPTIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI S.P.A. (IT) | 2001-03-21 | — | — | EP | disclosed |
| WO-1999064442-A1 | PEPTIDE INHIBITORS OF HEPATITIS C VIRUS NS3 PROTEASE | ISTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P ANGELETTI S.P.A. (IT) | 1999-12-16 | — | — | WO | disclosed |
| US-5750089-A | Halogenated neuroprobe for mapping monoamine reuptake sites | NEURO IMAGING TECHNOLOGIES, LLC (US) | 1998-05-12 | — | — | US | disclosed |
| EP-0831941-A1 | IODINATED NEUROPROBES FOR MAPPING MONOAMINE REUPTAKE SITES | Research Biochemicals, Limited Paternership, doing business as Research biochemicals International (US) | 1998-04-01 | — | — | EP | disclosed |
| US-5698179-A | Iodinated neuroprobe for mapping monoamine reuptake sites | NEURO IMAGING TECHNOLOGIES, LLC (US) | 1997-12-16 | — | — | US | disclosed |
| WO-1996039198-A1 | IODINATED NEUROPROBES FOR MAPPING MONOAMINE REUPTAKE SITES | RESEARCH BIOCHEMICALS, LIMITED PARTNERSHIP, doing business as RESEARCH BIOCHEMICALS INTERNATIONAL, A MASSACHUSETTS LIMITED PARTNERSHIP, WHOSE SOLE GENERAL PARTNER IS RBI MANAGEMENT, INC. (US) | 1996-12-12 | — | — | WO | disclosed |